This study aimed (1) to investigate the immunohistochemical expression of cancer stem cell markers NANOG and CD133 in endometrial hyperplasia and endometrial carcinoma and their correlation with different clinicopathological parameters and (2) to compare the expression of these markers in normal endometrial tissue and apparently normal tissue around the tumor. The gene discussed is PROM1; the disease is cancer.